Leadership

Sandeep Gupta, PhD

Asana BioSciences is led by Dr. Sandeep Gupta, who was previously the Senior Vice-President of Discovery and Early Development, Endo Pharmaceuticals. Prior to Endo, Dr. Gupta spent a decade at Forest Laboratories as Head of Drug Discovery and Pharmacology. He played a key role in the development of several block buster drugs during his tenure at Endo and Forest. Before Forest Laboratories, Dr. Gupta held academic positions at the University of Pennsylvania and Boston University Schools of Medicine. Regarded as an architect of the Virtual Drug Discovery Research model, he has pioneered several successful Discovery and Development collaborations across the globe. He is a co-inventor on multiple patents and has authored over 50 scientific papers, presentations and book chapters.

Sandeep Gupta,

Founder, President & Chief Executive Officer
Pablo-V2.jpg

Pablo Jimenez, MD, FAPRC  

Sr. Vice President & Chief Medical Officer

Dr. Jimenez is a Senior pharmaceutical executive physician with more than 20 years of experience in clinical research, regulatory, and medical affairs in the dermatology, rheumatology, and respiratory therapeutic areas. His product business development expertise includes atopic dermatitis, psoriasis, asthma and wound healing. Dr. Jimenez earned an MD degree from the Central University, Ecuador, and did his post-doctoral work at Brown University. He is a fellow of the Academy of Physicians in Clinical Research (FAPCR). He holds a successful track record in executive leadership positions at premier biopharmaceutical and pharmaceutical companies, such as Human Genome Sciences, Novartis, Celsus, and Ziarco. He is co-inventor on multiple patents and is co-author of numerous scientific publications and presentations. 

Niranjan Rao, PhD, FCP

Niranjan Rao, PhD FCP

Sr. Vice President, Development Sciences

Dr. Rao has 30 years of drug development experience in a variety of therapeutic areas at Aventis, Forest Laboratories, Kyowa Hakko Kirin Pharma and Endo Pharmaceuticals. He has held positions of increasing scope and responsibility over the course of his career.   He has led early clinical development programs in oncology and has been an important contributor on several NDAs and approved drugs. He is a co-inventor on multiple patents and has published or presented over 60 scientific papers.

Shawshank.jpg

Shashank Mahashabde

Sr. Vice President, CMC & Operations

Shashank Mahashabde has over 30 years of experience in the pharmaceutical industry in Research and Development at Schering Plough Research Institute and Forest Research Institute. He has extensive experience in development of all dosage forms and has been involved in several NDAs and development of 19 products on the market.  Most recently, he was President of Business Development and Marketing for North America at Neuland Laboratories Inc.  He has several applied and issued patents.

Yusong-Chen.jpg

Yusong Chen, PhD

Vice President Biostatistics & DM

Dr. Chen has over 28 years of experience in the pharmaceutical industry at AstraZeneca, GSK, Cephalon, Endo Pharmaceuticals and PAREXEL. His experience extended from innovative, generic, and biosimilar products from Phase I to Phase IV in a variety of therapeutic areas. He was an important contributor of multiple NDAs and approved medical products. He has held variety leadership positions in his career and most recently he was the VP of Center of Excellence/Biostatistics at PAREXEL. His statistical expertise includes modeling and simulation and innovative clinical trial designs. 

Scott.jpg

Scott K. Thompson, PhD

Executive Director, CMC Preclinical & Medicinal Chemistry

Dr. Thompson has close to 30 years of experience at Asana Biosciences, Endo Pharmaceuticals and GlaxoSmithKline in multiple areas of drug discovery and development, including medicinal chemistry, project leadership and management, compound library management and screening strategies, and API and drug product development and manufacture. He has conducted research in a variety of therapeutic areas including oncology, urology, inflammation and pain, and has been the leader for multiple projects that have produced clinical development candidates. Prior to joining Asana BioSciences, he was Director of Medicinal Chemistry at Endo Pharmaceuticals. Dr. Thompson is a co-inventor on more than 50 issued patents and patent applications, and is a co-author on over 35 peer-reviewed